PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Dihydrocodeine tartrate
Presentation Product Chemical substance Chapter Items dispensed
Dihydrocodeine 30mg tablets
0407020G0AAACAC
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System 125,041
Dihydrocodeine 60mg modified-release tablets
0407020G0AAADAD
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System 27,530
Dihydrocodeine 120mg modified-release tablets
0407020G0AAAFAF
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System 13,001
Dihydrocodeine 90mg modified-release tablets
0407020G0AAAEAE
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System 9,963
Dihydrocodeine 40mg tablets
0407020G0AAAIAI
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System 538
Dihydrocodeine 10mg/5ml oral suspension
0407020G0AAAPAP
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System 38
Dihydrocodeine 10mg/5ml oral solution
0407020G0AAAAAA
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System 9
Dihydrocodeine 15mg/5ml oral solution
0407020G0AAANAN
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System No data available
Dihydrocodeine 30mg/5ml oral solution
0407020G0AAAMAM
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System No data available
Dihydrocodeine 50mg/1ml solution for injection ampoules
0407020G0AAABAB
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System No data available
Dihydrocodeine 60mg/5ml oral liquid
0407020G0AAARAR
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System No data available
Dihydrocodeine 90mg/5ml oral solution
0407020G0AAAKAK
Dihydrocodeine tartrate Dihydrocodeine tartrate Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.